Postoperative adjuvant chemotherapy for non-small-cell lung cancer

ONCOLOGY

Volumn 11, Issue 9 SUPPL. 10, 1997, Pages 98-102

  Wada, Hiromi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOMYCIN; MITOMYCIN C; TEGAFUR; UFT; VINDESINE;

ADENOCARCINOMA; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; JAPAN; LUNG NON SMALL CELL CANCER; POSTOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DRUG COMBINATIONS; HUMANS; JAPAN; LUNG NEOPLASMS; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE; TEGAFUR; URACIL;

EID: 0030734611     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Holmes EC, Gail M: Lung Cancer Study Group: Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma. J Clin Oncol 4:710-715, 1986.
2. Niiranen A, Niitamo-Korhonen S, Kouri M, et al: Adjuvant chemotherapy after radical surgery for non-small cell lung cancer: Randomized study. J Clin Oncol 10:1927-1932, 1992.
3. Shimizu N, Teramoto S, Hitomi S, et al: A randomized controlled postoperative adjuvant chemotherapy trial of MMC + Tegafur and MMC + UFT for adenocarcinoma of the lung - first study. Jpn J Lung Cancer 31:1011 -1019, 1991.